Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells. (2015)

Peer-Reviewed Study · Bhatt AN; Chauhan A; Khanna S; Rai Y; Singh S; Soni R; Kalra N; Dwarakanath BS · May 1, 2015

Bhatt AN et al., 2015-05-01: Cell-line study in which methylene blue, used as a mitochondrial respiratory modifier, increased glycolysis (GLUT-1 and HK-II up, doubled glucose consumption and lactate output) and thereby made human cell lines resistant to radiation – the opposite direction to the claim that methylene blue cuts off the cancer cell's glycolytic energy supply.

MRMs induced the glycolysis by enhancing the levels of two important regulators of glucose metabolism GLUT-1 and HK-II and resulted in 2 fold increase in glucose consumption and lactate production. This increase in glycolysis resulted in resistance against radiation-induced cell death (clonogenic survival) in different cell lines at an absorbed dose of 5 Gy.

Bhatt AN et al., 2015-05-01: Cell-line study in which methylene blue, used as a mitochondrial respiratory modifier, increased glycolysis (GLUT-1 and HK-II up, doubled glucose consumption and lactate output) and thereby made human cell lines resistant to radiation – the opposite direction to the claim that methylene blue cuts off the cancer cell's glycolytic energy supply. C1 Bhatt 2015 (contrary). Study type: in vitro cell-line study (HEK293, BMG-1, OCT-1 human lines); N/A. Country: India (Institute of Nuclear Medicine and Allied Sciences, Delhi). Dose: methylene blue concentration not stated in the abstract text captured; MB used alongside dinitrophenol and Photosan-3 as 'mitochondrial respiratory modifiers'. Route: in vitro. Funder: 'Research Support, Non-U.S. Gov't' per PubMed; specific funder not in the record. Conflicts: no COI statement in the record. Comparator: untreated irradiated cells; glycolysis inhibitors (fasentin, 2-deoxy-D-glucose, 3-bromopyruvate) as controls. Records MB as a glycolysis-STIMULATING agent, so it cuts against the source's 'interferes with glycolysis' framing. Also filed as MTE-15, MTM-18 (claims C1, C2, C3). Study type: lab.